Cox Terhorst

Active 1972–2024

142
Papers
26,833
Citations
99
h-index
142
i10-index

Citations

Citations per year for Cox Terhorst1972: 7 citations1973: 4 citations1974: 8 citations1975: 8 citations1976: 5 citations1977: 7 citations1978: 25 citations1979: 30 citations1980: 20 citations1981: 32 citations1982: 58 citations1983: 93 citations1984: 104 citations1985: 147 citations1986: 199 citations1987: 235 citations1988: 237 citations1989: 193 citations1990: 209 citations1991: 178 citations1992: 132 citations1993: 103 citations1994: 104 citations1995: 122 citations1996: 104 citations1997: 128 citations1998: 172 citations1999: 176 citations2000: 200 citations2001: 219 citations2002: 213 citations2003: 226 citations2004: 242 citations2005: 230 citations2006: 222 citations2007: 251 citations2008: 244 citations2009: 189 citations2010: 264 citations2011: 203 citations2012: 179 citations2013: 165 citations2014: 147 citations2015: 136 citations2016: 117 citations2017: 128 citations2018: 118 citations2019: 317 citations2020: 381 citations2021: 381 citations2022: 283 citations2023: 249 citations2024: 369 citations2025: 194 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,809 citing papers, 40.9% of this breakdownUnited Kingdom: 609 citing papers, 6.5% of this breakdownGermany: 569 citing papers, 6.1% of this breakdownChina: 443 citing papers, 4.8% of this breakdownFrance: 420 citing papers, 4.5% of this breakdownJapan: 380 citing papers, 4.1% of this breakdownCanada: 341 citing papers, 3.7% of this breakdownItaly: 293 citing papers, 3.1% of this breakdownNetherlands: 260 citing papers, 2.8% of this breakdownAustralia: 248 citing papers, 2.7% of this breakdownSwitzerland: 226 citing papers, 2.4% of this breakdownSpain: 185 citing papers, 2% of this breakdown
0%40.9%Other 16.4%

Fields

  • Medicine35.8%
  • Immunology and Microbiology35.7%
  • Biochemistry, Genetics and Molecular Biology24.8%
  • Neuroscience1.6%
  • Agricultural and Biological Sciences0.5%
  • Engineering0.3%
  • Other1.3%

Topics

  • Immune Cell Function and Interaction11%
  • T-cell and B-cell Immunology10.3%
  • Immunotherapy and Immune Responses3.8%
  • Hematopoietic Stem Cell Transplantation3.6%
  • Monoclonal and Polyclonal Antibodies Research3.4%
  • CAR-T cell therapy research2.4%
  • Other65.5%

Coauthors

All papers

Open in search
  1. Immune Responses to Viral Gene Therapy Vectors

    Authors: , , , - Molecular Therapy 2020 cited by 751

  2. SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells

    Authors: , , , , , - Cell 2005 cited by 3,153

  3. Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells

    Authors: , , , , , , , , , , , , - Blood 2017 cited by 123

  4. TLR9-independent CD8+ T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signaling

    Authors: , , , , , , , , , , , , , , - Molecular Therapy 2023 cited by 26

  5. Roles of CD48 in regulating immunity and tolerance

    Authors: , , - Clinical Immunology 2016 cited by 217

  6. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2016 cited by 99

  7. The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose

    Authors: , , , , - Molecular Therapy 2017 cited by 77

  8. SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer

    Authors: , , , , , , , , , , , , , - Cancer Immunology Research 2019 cited by 69

  9. Role of orally induced regulatory T cells in immunotherapy and tolerance

    Authors: , , , , , - Cellular Immunology 2020 cited by 88

  10. Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells

    Authors: , , , , , , , , , - Molecular Therapy 2019 cited by 74

  11. Innate Immune Sensing of Adeno-Associated Virus Vectors

    Authors: , , , , , , - Human Gene Therapy 2024 cited by 41

  12. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tgϵ26 mice

    Authors: , , , , , , , - Gastroenterology 2001 cited by 149

  13. IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice

    Authors: , , , , , , , , , , , , , , , , - Molecular Therapy 2022 cited by 34

  14. Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes

    Authors: , , , , , , , - Nature 1995 cited by 295

  15. T cells as therapeutic targets in SLE

    Authors: , , , - Nature Reviews Rheumatology 2010 cited by 267

  16. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells

    Authors: , , , , , , , , , , , , - Blood 2013 cited by 158

  17. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

    Authors: , , , , , , , , , , , , , - Nature 1998 cited by 945

  18. SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages

    Authors: , , , , , , , , , , , , , - Nature Immunology 2010 cited by 172

  19. The SLAM and SAP Gene Families Control Innate and Adaptive Immune Responses

    Authors: , , , , , , - Advances in immunology 2008 cited by 164

  20. Homotypic Interactions Mediated by Slamf1 and Slamf6 Receptors Control NKT Cell Lineage Development

    Authors: , , , , , , , , - Immunity 2007 cited by 340

  21. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer

    Authors: , , , , , , - Blood 2007 cited by 215

  22. CD38 is functionally dependent on the TCR/CD3 complex in human T cells

    Authors: , , , , - The FASEB Journal 1998 cited by 114

  23. Responses to Microbial Challenges by SLAMF Receptors

    Authors: , , , - Frontiers in Immunology 2016 cited by 76

  24. B cell focused transient immune suppression protocol for efficient AAV readministration to the liver

    Authors: , , , , , , , , , , , - Molecular Therapy — Methods & Clinical Development 2024 cited by 19